Vitaspring Biomedical VSBC
OTC VSBC
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Gains from Equity Investments (2020 - 2021)

Updated

Analysis

Vitaspring Biomedical (VSBC) Gains from Equity Investments (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.92 Bn 1,102.51 Bn 19.71 Bn
2 Johnson & Johnson 634.72 Bn 554.59 Bn 17.30 Bn
3 AbbVie 506.31 Bn 479.42 Bn 12.70 Bn
4 Merck 357.83 Bn 312.21 Bn 12.21 Bn
5 Novartis Ag 291.64 Bn 255.63 Bn 11.24 Bn
6 Astrazeneca 265.27 Bn 238.96 Bn 12.86 Bn
7 Amgen 238.30 Bn 193.70 Bn 7.24 Bn
8 Gilead Sciences 195.34 Bn 169.53 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 Vitaspring Biomedical 6.21 Mn 6.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2021 235,662.00
Apr 30, 2020 -17,745.00
API Access

Vitaspring Biomedical Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=VSBC&period=max&api_key=YOUR_API_KEY